AMBUJACEM Share Price Target 2040

CAGR-based price projection for Ambuja Cements Limited (AMBUJACEM) targeting 2040, derived from official NSE exchange closing prices.

Bear Case (-5.0% CAGR)
Rs 177
2040 Target
Base Case (-18.6% CAGR)
Rs 20
2040 Target
Bull Case (-27.9% CAGR)
Rs 4
2040 Target

Current Market Snapshot

CMP: Rs 362.25
52W High: Rs 460.90
52W Low: Rs 362.25
1Y CAGR: -33.8%
3Y CAGR: -18.6%

Year-by-Year Price Projection

YearBear CaseBase CaseBull Case
2027 Rs 344 Rs 295 Rs 261
2028 Rs 327 Rs 240 Rs 188
2029 Rs 311 Rs 195 Rs 136
2030 Rs 295 Rs 159 Rs 98
2031 Rs 280 Rs 129 Rs 70
2032 Rs 266 Rs 105 Rs 51
2033 Rs 253 Rs 86 Rs 37
2034 Rs 240 Rs 70 Rs 26
2035 Rs 228 Rs 57 Rs 19
2036 Rs 217 Rs 46 Rs 14
2037 Rs 206 Rs 37 Rs 10
2038 Rs 196 Rs 31 Rs 7
2039 Rs 186 Rs 25 Rs 5
2040 Rs 177 Rs 20 Rs 4

Other AMBUJACEM Price Targets

2025 2026 2027 2028 2030 2035 2050

Frequently Asked Questions

What is the AMBUJACEM share price target for 2040?

Based on historical growth analysis, the AMBUJACEM share price target for 2040 ranges from Rs 177 (conservative) to Rs 20 (base case) to Rs 4 (optimistic). These projections are based on trailing CAGR and should not be treated as guaranteed outcomes.

What is the current share price of AMBUJACEM?

The current market price of AMBUJACEM (Ambuja Cements Limited) is Rs 362.25. The 52-week high is Rs 460.90 and 52-week low is Rs 362.25.

Is AMBUJACEM a good stock to buy for the long term?

Long-term investment decisions depend on individual risk tolerance, financial goals, and portfolio diversification. Examine the company's fundamentals, debt-to-equity ratio, promoter holding, and competitive positioning within its sector. BrokerLens provides data-driven analysis; consult a SEBI-registered financial advisor before investing.

What methodology does BrokerLens use for AMBUJACEM price targets?

BrokerLens computes price targets using historical Compound Annual Growth Rate (CAGR) derived from official NSE closing prices. Three scenarios are modeled: Bear (conservative at -5.0% CAGR), Base (-18.6% CAGR), and Bull (optimistic at -27.9% CAGR). These are statistical projections, not guaranteed forecasts.

Disclaimer: Share price targets on BrokerLens are statistical CAGR projections based on historical NSE closing prices. They are NOT guaranteed outcomes, investment advice, or analyst recommendations. Past performance does not guarantee future results. Consult a SEBI-registered investment advisor before making investment decisions. Mutual fund and equity investments are subject to market risks.